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TGFβ1 reinforces arterial aging in 
the vascular smooth muscle cell 
through a long-range regulation of 
the cytoskeletal stiffness
Wanqu Zhu1, Byoung Choul Kim2,3,4,5, Mingyi Wang  6, Jessie Huang1, Abraham Isak1,  
Natalia M. Bexiga7, Robert Monticone6, Taekjip Ha  2,3,4, Edward G. Lakatta6 & Steven S. An1,8,9
Here we report exquisitely distinct material properties of primary vascular smooth muscle (VSM) cells 
isolated from the thoracic aorta of adult (8 months) vs. aged (30 months) F344XBN rats. Individual VSM 
cells derived from the aged animals showed a tense internal network of the actin cytoskeleton (CSK), 
exhibiting increased stiffness (elastic) and frictional (loss) moduli than those derived from the adult 
animals over a wide frequency range of the imposed oscillatory deformation. This discrete mechanical 
response was long-lived in culture and persistent across a physiological range of matrix rigidity. 
Strikingly, the pro-fibrotic transforming growth factor β1 (TGFβ1) emerged as a specific modifier of age-
associated VSM stiffening in vitro. TGFβ1 reinforced the mechanical phenotype of arterial aging in VSM 
cells on multiple time and length scales through clustering of mechanosensitive α5β1 and αvβ3 integrins. 
Taken together, these studies identify a novel nodal point for the long-range regulation of VSM stiffness 
and serve as a proof-of-concept that the broad-based inhibition of TGFβ1 expression, or TGFβ1 signal 
transduction in VSM, may be a useful therapeutic approach to mitigate the pathologic progression of 
central arterial wall stiffening associated with aging.
Increased stiffness of central arteries as measured by pulse wave velocity (PWV) is a major risk factor for a broad 
spectrum of cardiovascular diseases (CVD)1,2, and is an independent predictor for CVD-associated morbidity 
and mortality in Western society3. Stiffening of these large elastic arteries is now construed as time-dependent4, 
and when considered with other covariates inherent in Western lifestyle, increases exponentially in human 
beyond the age of 40 years5. In the United States alone, it is estimated that 35 million individuals are older than 
65 years6. As the average age of population projected to grow markedly in the coming decades, there is an unmet 
clinical need for understanding the nature of arterial aging, and developing new therapeutic modalities to prevent 
or treat the pathologic progression of age-associated arterial wall stiffening.
The Fisher 344, or, cross-bred Brown Norway (F344XBN) rats have emerged as a good animal model of arte-
rial aging7, exhibiting age-related structural changes in the vascular wall that are grossly congruent with the 
physiologic changes in human lifetime8–11. For example, analogous to the ‘normal’ aging in humans, the aortic wall 
of aged F344XBN rats is marked by low-grade inflammation, the emergence of pro-fibrotic transforming growth 
factor β1 (TGFβ1), and thickening of the intima, media and adventitia layers12,13. Further, within these layers of 
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the aortic wall, there is loss of elastin, gain of collagen and fibronectin8,12,13 as well as accumulation and infiltra-
tion of α-smooth-muscle-actin positive structural cell types9,11,14. Some of these structural changes have been 
also documented in other aging studies employing different experimental animals, from mice to non-human 
primates, and under physiologic and pathologic conditions15–18.
The current view stipulates that age-associated stiffening of the central arteries is largely attributable to 
changes in the structural composition and the elasticity of extracellular matrix (ECM) in the vascular wall that are 
driven by pro-inflammatory milieu and accentuated by pre-existing metabolic syndrome, diabetes and hyperten-
sion19–21. Contribution of vascular smooth muscle (VSM), the structural cell-types of the vascular wall, to arterial 
remodeling/stiffening is poorly understood. In addition, the molecular-level mechanical transgression in VSM 
cells forcing age-associated stiffening of central arteries is unknown.
Using F344XBN experimental model, here we explored the stiffness landscape of arterial aging in VSM, at 
the single-cell resolution, with magnetic twisting cytometry (MTC). Compared with primary VSM cells derived 
from adult rats (8 months), those derived from aged rats (30 months) exhibited increased stiffness deep within 
the cytoskeletal structures. The increase in cell stiffness was persistent in culture, prevailed under a wide vari-
ety of matrix rigidities, and positively associated with TGFβ1 expression and its receptor activation. Applying 
small-scale tension gauge tether (TGT) and large-scale Fourier transform traction microscopy (FTTM) methods, 
we further demonstrated that the mechanical phenotype of arterial aging in VSM cells is reinforced by TGFβ1 and 
is propagated, at long distance, through a cluster of mechanosensitive integrin receptors α5β1 and αvβ3.
Results and Discussion
Cellular models of physiologic arterial aging in vitro. There is a widespread agreement that increased 
smooth muscle mass (i.e. hyperplasia and hypertrophy), as well as alterations in the amount and composition of 
ECM (i.e. collagen and fibronectin) are the major contributing factors for age-associated remodeling and stiff-
ening of the arterial wall22,23. As reported previously24, compared with adult (8 months) F344XBN rats, aged (30 
months) rats showed anatomically distinct structural remodeling in the central aorta and, in particular, thick-
ening of the intima, media and adventitia layers (Suppl. Fig. 1a). Moreover, consistent with earlier studies14,18, 
primary VSM cells–as marked by the expression of smooth muscle myosin heavy chains and α-smooth-muscle 
actin (Suppl. Fig. 1b,c)–derived from the aged rats proliferated at a faster rate in culture than those derived from 
the respective aortic segments of adult rats (Suppl. Fig. 1d).
Using this phenotypically, and epigenetically, well-congruent cellular model of physiologic aging8–11, here we 
interrogated the physical state of these structural cell types of the central aorta applying a series of live cell micro-
mechanical methods. Herein, we used ‘young’ vs. ‘old’ to describe individual VSM cells derived from the adult (8 
months) vs. aged (30 months) rats. For these studies, we used isolated primary VSM cells that had been passaged 
in standard culture media and under identical experimental conditions.
Age-associated changes in the material properties of VSM cells deep within the cytoskeletal 
network. First, we applied spontaneous motions of microbeads functionalized to the living cytoskeleton 
(CSK)25–31 and measured the rate of CSK remodeling in isolated primary VSM cells (Suppl. Fig. 2). In both 
young and old VSM cells, the computed mean square displacements (MSD) of unforced bead motions in 2D 
increased with time (t) as a power law with an exponent α greater than unity (~1.6; Suppl. Fig. 2b,c), indicating 
non-thermal, molecular-level fluctuations of the underlying CSK structures32,33. Such non-Brownian dynamics of 
the cytoskeletal network were unremarkably similar in both young and old VSM cells, though (Suppl. Fig. 2c,d).
In order to probe deeper into the mechanical properties of the underlying cytoskeletal structures, and the 
molecular relaxation processes that might be associated with aging, we next applied forced motions of the same 
functionalized beads with magnetic twisting cytometry (MTC)26,31,34. For each individual VSM (young vs. old), 
we computed the elastic modulus g’ (stiffness), the loss or viscous modulus g” (internal friction), and the loss 
tangent η (the ratio of g”/g’) over a wide frequency range. Throughout the measurement range (oscillatory fre-
quencies from 10−1 to 103 Hz), the stiffness of VSM cells (young and old) increased with frequency (f) as a weak 
power law (Fig. 1a). The internal friction or energy dissipation also followed a weak power law at low frequencies 
(below ~10 Hz), with nearly the same exponent as did the stiffness of young (f 0.154) and old (f 0.149) VSM cells 
(Fig. 1a). At higher frequencies (above ~10 Hz), however, the dissipative response showed a progressively stronger 
frequency dependence, approaching but never quite attaining a power-law exponent of 1–i.e. characteristic of a 
Newtonian viscosity34.
Accordingly, consistent with the original work by Fabry et al.34, over a five decade of frequency, molecular 
dynamics of the cytoskeletal network within the VSM derived from the classically elastic arteries were also distrib-
uted broadly. There were many relaxation processes contributing when the frequency of the imposed deformation 
was small, but very few as the frequency was increased and slower processes became progressively frozen out of 
the response. This class of single-cell rheological response is empirically in line with the mechanical behavior of 
cell-ensemble in living tissues35, and is equivalent to the macroscopic rheological properties of arterial wall2,36.
As shown in Fig. 1a,b, however, the power-law frequency dependence of stiffness (g’) and friction (g”) dif-
fered appreciably between young vs. old VSM cells, including the loss tangent η and the derived parameter ‘x’–
the so called an ‘effective temperature’ of the cytoskeletal matrix (young VSM, x = 1.174 ± 0.003 vs. old VSM, 
x = 1.162 ± 0.003; Mean ± SE, n = 298–466 individual cell measurements; P < 0.005)34. For example, if g’(f) 
goes as ~f x−1, x represents effective matrix temperature and determines where the cells sit along a continuous 
spectrum of solid-like (x = 1) vs. liquid-like (x = 2) states26,30,34. In the limit that x approaches 1, the behavior 
approaches that of a Hookean elastic solid and, in the limit in which x approaches 2, the behavior approaches that 
of a Newtonian viscous fluid. Hence, purely as a matter of phenomenology, individual VSM cells derived from 
aged rats are in a physical state that is more solid-like and closer to a glass transition than those derived from adult 
rats26,31,34.
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Most strikingly, these material behaviors of isolated primary VSM cells and, in particular, the increased 
cytoskeletal stiffness in old VSM cells was persistent in culture (Fig. 1c) and prevailed under a wide range of 
matrix rigidities in the physiologic spectrum of arterial wall stiffness (Fig. 1d and Suppl. Fig. 3). These results 
indicate a long retention/memory of material stiffness in VSM cells that is hardwired, and perhaps epigenetically 
regulated, to arterial aging.
Phenotypic expression of increased cytoskeletal stiffness is linked to canonical TGFβ1 signal 
transduction in VSM cells. In aged rats, we had identified an altered pro-fibrotic TGFβ1 expression within 
the α-smooth-muscle actin-rich compartment of the stiffened aortic wall13. Consistent with these results, pri-
mary VSM cells isolated from aged rats retained in vitro higher expression levels of latent TGFβ1 than those 
derived from adult rats (Fig. 2a). At baseline condition, the phosphorylation levels of Smad2/3 were also higher 
Figure 1. Material properties of young vs. old VSM cells as measured by MTC. (a) Using MTC, we measured 
cell stiffness (g’, storage modulus) and internal friction (g”, loss modulus) over 5 decades of probing frequency. 
Data are presented as Geometric Mean ± SE (young VSM, n = 466 cells; old VSM, n = 298 cells). The solid 
lines are the fit of experimental data to the structural damping equation with addition of a Newtonian viscous 
term as previously described34. A shaded box indicates statistical differences between young vs. old VSM cells. 
(b) Corresponding hysteresivity η (the ratio of g” to g’) detected at 0.75 Hz. Data are presented as Mean ± SE. 
(c) Stiffness of VSM cells adhered on collagen-coated plastic wells cultured in media containing a varying 
FBS concentration (0.1–10%). Data are presented as Geometric Mean ± SE (n = 113–195 individual cell 
measurements for each condition). (d) Stiffness of VSM cells (1% FBS) cultured on collagen-coated elastic 
gels with varying rigidity (1–20 kPa with Poisson’s ratio of 0.48). Data are presented as Geometric Mean ± SE 
(1 kPa, n = 175–370 individual cell measurements; 8 kPa, n = 68–119 individual cell measurements; 20 kPa, 
n = 401–520 individual cell measurements). *P < 0.05; **P < 0.01; ****P < 0.0001. Herein, we report cell 
stiffness measured at 0.75 Hz. For measured stiffness and friction over 5 decades of probing frequency, please 
see Supplementary Figure 3.
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in old VSM cells (Fig. 2b,c), suggesting an inherent activation of the TGFβ1 receptor in old VSM cells. Of note, 
exogenous addition of TGFβ1 increased the phosphorylation levels of Smad2/3 in both young and old VSM cells; 
however, the increase was more robust in young VSM cells (Fig. 2b,c).
At baseline condition, old VSM cells showed appreciable increases in the filamentous actin (F-actin) and the 
expression of focal adhesion protein vinculin than young VSM cells (Fig. 3). In young VSM cells, exogenous addi-
tion of TGFβ1 increased F-actin polymerization (Fig. 3a,b) and stiffened the cytoskeletal network (Fig. 4a), which 
were comparable to old VSM cells. TGFβ1 did not significantly modify the cytoskeletal structure and function in 
old VSM cells (Figs 3a,c and 4a). Of note, old VSM cells treated with TGFβ1 exhibited markedly attenuated and 
delayed reduction in cytoskeletal stiffness in response to cytochalasin-D, an inhibitor of F-actin polymerization 
(Suppl. Fig. 4a). On the same time scale, blebbistatin, a myosin ATPase inhibitor, did not significantly modify 
the stiffness of young vs. old VSM cells, even in the presence of TGFβ1 (Suppl. Fig. 4a). These results suggest that 
TGFβ1 reinforces the mechanical phenotype of arterial aging in VSM cells through a long-range regulation of the 
actin CSK network.
Consistent with this structure-function relationship, siRNA-mediated knockdown of TGFβ1 decreased 
the stiffness of old VSM cells (Fig. 4b,c). In addition, pharmacological inhibition of the canonical TGFβ1 
Figure 2. TGFβ1 expression and signaling in VSM cells. (a) Production of TGFβ1 by young vs. old VSM cells 
as detected by sandwich enzyme-linked immunosorbent assay. Data are presented as Mean ± SD (n = 3). (b,c) 
VSM cells (young and old) were treated for 24 h with or without 5 ng/ml TGFβ1. (b) Phosphorylation levels of 
Smad2/3 were detected by western blot (Full gel/blot is shown in the Supplementary Figure 5). (c) Quantitation 
of the protein levels. Data are expressed as Mean ± SD (n = 3). *P < 0.05 (untreated vs. TGFβ1 treated); 
#P < 0.05 (young vs. old).
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receptor-Smad2/3 signaling with GW788388 and A-83–01 decreased the stiffness of old VSM cells in a 
concentration-dependent manner (Fig. 4d). In young VSM cells, GW788388 and A-83-01 effectively inhibited, 
in turn, TGFβ1-induced Smad2/3 phosphorylation (Suppl. Fig. 5) and TGFβ1-induced cell stiffening (Fig. 4e). 
Collectively, these results suggest that arterial aging modifies the stiffness of VSM cells and that this mechanical 
transgression deep within the cell body (i.e. cytoskeletal structures) is regulated by TGFβ1 via its canonical signal 
transduction pathways.
TGFβ1 modifies the expression of mechanosensitive integrin receptors. The cell surface integrin 
receptors play a critical role in sensing the external molecular microenvironment, as well as transducing these 
mechanical and/or chemical cues into physical forces that are necessary for cell adhesion, migration, contrac-
tion, and proliferation. Using RT-PCR, we assessed the transcript levels of α and β integrin subunits that when 
dimerized bind to ECM proteins of the vascular wall (i.e. collagen, laminin, and fibronectin)8,12,13, as well as αvβ6 
which is reported to physically liberate TGFβ1 from its latency37–40. Although old VSM cells showed apprecia-
ble increases in the mRNA levels of α3, α7, β3 and β5 integrin subunits than young VSM cells, we did not detect 
noticeable differences in the transcript levels of integrin subunits responsible for binding to collagen (α1β1, α2β1) 
and fibronectin (α5β1, αvβ3), as well as for activating the pro-TGFβ1 (αvβ6) (Suppl. Fig. 7, untreated cells).
Interestingly, in both young and old VSM cells, exogenous addition of TGFβ1 decreased the mRNA levels 
of integrin α subunits (α1, α2, α3, and α7) responsible for binding to collagen and/or laminin whereas increased 
α5 and αv integrin subunits for binding to fibronectin (Suppl. Fig. 7). In young VSM cells, TGFβ1 treatment 
also increased the mRNA levels of β1 and β6 integrin subunits (Suppl. Fig. 7). Due to the poor sensitivity of the 
commercially available antibodies, we could only confirm the protein abundance of α5β1, but not αvβ3 or αvβ6, by 
western blot (Suppl. Fig. 8a). As shown in Supplementary Figure 8b, though, isolated primary VSM cells stained 
positive for α5β1 and αvβ3. At baseline, the fluorescence intensities of α5β1 and αvβ3 were appreciably higher in old 
VSM cells than young VSM cells. By contrast, young VSM cells treated with TGFβ1 showed comparable α5β1 and 
αvβ3 staining to that of old VSM cells (Suppl. Fig. 8b). Taken together, these series of studies showed that TGFβ1 
expression, or TGFβ1 receptor activation, in VSM cells increases the expression of α5β1 and αvβ3–the primary 
integrin receptors for fibronectin41,42.
TGFβ1 reinforces the molecular tension in VSM cells through a cluster of α5β1 and αvβ3 integrins. 
In order to assess the extent to which TGFβ1-induced VSM stiffening is reinforced through these mechanosensi-
tive fibronectin-specific integrin receptors, we next applied single-molecule ‘tension gauge tether (TGT)’ method 
(Suppl. Fig. 9)43,44. TGT is a rupturable double stranded DNA (dsDNA), which is designed to rupture under a 
critical force (Ttol, tension tolerance). Ttol is controlled by biotins precisely located on the bottom DNA strand; 
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Figure 3. Immunofluorescent detection of actin cytoskeletal structures in VSM cells. VSM cells (young 
and old) were treated for 24 h with or without 5 ng/ml TGFβ1, and the internal cytoskeletal structures were 
visualized with actin cytoskeleton/focal adhesion staining kit as described in the Methods (a). Scale bar is 
20 µm. Average fluorescent intensities of (b) phalloidin and (c) vinculin per cell from multiple images are 
presented as Mean ± SE (Young: n = 7; Young + TGFβ1: n = 5; Old: n = 7; Old + TGFβ1: n = 6). *P < 0.05; 
**P < 0.01; ***P < 0.001.
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and, the molecular tension of a single receptor-ligand bond is characterized through a specific receptor motifs 
conjugated to the upper DNA strand (Suppl. Fig. 9). For these studies, we used cyclic-RGDfK pentapeptide, 
which is the receptor motif for α5β1 and αvβ343,44.
At short times (30 min), isolated VSM cells from both adult and aged rats adhered and spread on the 54 pN 
TGT surface, but did not pull apart dsDNA tethers (Suppl. Fig. 10; no loss of fluorescence signal in the Cy3 chan-
nel). These results are consistent with previous studies showing a universal molecular force of a single integrin 
receptor being ~40 pN tension44. As such, an individual cell is able to form a stable adhesion on 54 pN TGT 
because Ttol = 54 pN is sufficient to bear the pulling force of a single ligand-integrin bond exerted by a living cell. 
In contrast, the extent of cellular adhesion and spreading was short-lived and remarkably low on the 23 pN TGT 
surface (Suppl. Fig. 10a,b).
Figure 4. Functional changes in the cytoskeletal stiffness by TGFβ1. (a) VSM cells (young and old) were 
treated for 24 h with or without 5 ng/ml TGFβ1, and changes in cell stiffness were measured by MTC. Data 
are presented as Geometric Mean ± SE (n = 175–410 individual cell measurements). (b) Old VSM cells were 
transfected with 25 nM small interference RNA (siRNA) against TGFβ1. After 48 h of transfection, TGFβ1 
protein level was determined by western blot (Full gel/blot is shown in the Supplementary Figure 6). (c) Stiffness 
of old VSM cells transfected with control or siRNA against TGFβ. Data are presented as Geometric Mean ± SE 
(n = 112–162 individual cell measurements). (d) Stiffness of old VSM cells treated for 24 h with TGFβ1 receptor 
inhibitors, A8301 and GW788388 (0–10 μM). Data are presented as Geometric Mean ± SE (n = 184–338 
individual cell measurements). (e) TGFβ1-induced cell stiffness in young VSM cells treated for 24 h with or 
without the inhibitors (10 μM A8301 and 10 μM GW788388). DMSO (0.1%) was used as control. Data are 
presented as Geometric Mean ± SE (n = 439–477 individual cell measurements). *P < 0.05; ****P < 0.0001.
www.nature.com/scientificreports/
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Of note, whereas old VSM cells were less adhered to 23 pN TGT than young VSM cells (Suppl. Fig. 10a), they 
were able to pull apart dsDNA tethers from the surface, marking behind clearly visible ‘entire’ rupture patterns 
(i.e. loss of fluorescence signal at the ligand-receptor contact area)44 (Suppl. Fig. 10c). In contrast, young VSM 
cells adhered to the 23 pN TGT surface produced ruptures that were smaller in magnitude and predominantly 
localized at the cell periphery (edge’ ruptures)44 (Suppl. Fig. 10c). Interestingly, young VSM cells treated with 
TGFβ1 became less adhered to the 23 pN TGT surface and, as did old VSM cells, made ‘entire’ rupture patterns 
(Suppl. Fig. 10a–c).
At longer time (t = 2 h), isolated VSM cells derived from both adult and aged rats adhered and spread on the 
23–54 pN TGT surface (Fig. 5a–d). Although old VSM cells were less adhered on the surface (Fig. 5b, on both 23 
pN and 54 pN TGT), the adherent cells were significantly bigger than young VSM cells (Fig. 5c). Of note, old VSM 
cells produced ‘entire’ ruptures on 23 pN TGT, as seen at short time (Suppl. Fig. 10c), while young VSM cells made 
ruptures that were predominantly localized to the cell periphery (‘edge’ ruptures)44 (Fig. 5d). On the other hand, 
both young and old VSM cells marked ‘edge’ ruptures on the 54 pN TGT surface; however, the ruptures were 
more pronounced in old VSM cells (Fig. 5d; i.e. bigger rupture widths). Strikingly, similar to old VSM cells, young 
VSM cells treated with TGFβ1 marked bigger dsDNA ruptures at the cell periphery (Fig. 5) that corresponded, in 
turn, to the site of focal adhesions (Suppl. Fig. 11).
Taken together, these results revealed a discordant spatiotemporal evolution of molecular tension in young vs. 
old VSM cells and that this short-range physical force at the single receptor-ligand bond is reinforced by TGFβ1. 
The data also showed that, within the early stages of cell adhesion, the single-molecule force exerted by an indi-
vidual young VSM cell through α5β1 and/or αvβ3 is less than 23 pN, and increased upon TGFβ1 treatment, to an 
equivalent molecular tension of an old VSM cell–i.e. greater than 23 pN, but less than 54 pN.
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Figure 5. Cell adhesion and spreading on TGT surfaces (incubation time, t = 2 h). (a) A schematic of TGT 
assay. (b) Total number of adherent VSM cells on 23 and 54 pN TGT surfaces. The number of adherent cells 
after 2 h incubation was counted. The TGT assay in each condition was repeated at least three times. Data are 
presented as Mean ± SE (n = 3 or 4). (c) Measured projected area of each adherent cell on 23 and 54 pN TGT 
surfaces. Data are presented as Mean ± SE. On 23 pN TGT surface: n = 19, old VSM; n = 37, young VSM; 
n = 61, young VSM with TGFβ1. On 54 pN TGT surface: n = 25, old VSM; n = 171, young VSM; n = 348, 
young VSM with TGFβ1. (d) TGT rupture patterns marked by an individual VSM cell. Cell boundary is drawn 
in white line. dsDNA tethers rupture (fluorescence signal loss in the Cy3 channel) when a stronger molecular 
tension above a tension tolerance (Ttol) is applied on a receptor-ligand bond. Scale bar is 25 µm. *P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001.
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Large-scale stress field in aging VSM cells. To assess the extent to which single-molecule integrin pull-
ing force is transmitted to large-scale cellular behaviors, we measured the traction stress arising at the interface 
between each adherent cell and the elastic matrix using Fourier transform traction microscopy (Fig. 6, Young’s 
modulus of ~8 kPa). Compared with young VSM cells, old VSM cells were appreciably bigger in size (Fig. 6a,b) 
and showed marked increases in traction (root mean square) average over the entire cell projected area (Fig. 6c). 
The average traction stress generation of old VSM cells (599.5 ± 89.1 Pa; Mean ± SE, n = 8) was ~68% greater 
than that of young VSM cells (356.0 ± 37.2 Pa; Mean ± SE, n = 10). From the computed traction stress, we also 
derived a number of other metrics of intracellular force, including the maximum cumulative force, strain energy 
imparted by the cell to the substrate, the tensional stress borne by actin microfilaments, and the amplitude of net 
contractile moment (Fig. 6d–g). All computed physical metrics of forces were significantly greater in old VSM 
cells than young VSM cells. In particular, compared with young VSM cells, old VSM cells showed an approxi-
mately four-fold higher net contractile moment (104.1 ± 33.9 vs. 23.5 ± 3.2 pNm; P = 0.0171), which is a scalar 
measure of the cell’s contractile strength45.
Of note, both basal tone and TGFβ1-induced stress were appreciably higher in old VSM cells than young 
VSM cells and irrespective of the matrix stiffness (Suppl. Fig. 12, Young’s Modulus of ~20 kPa). Taken together, 
these data established that molecular tension of greater than 54 pN is concentrated at an individual integrin-focal 
adhesion cluster and is propagated, at long distance, through a tense network of internal cytoskeleton to generate 
stress field in isolated primary VSM cells. Importantly, these results demonstrated that such long-range regulation 
of cytoskeletal structures is modified by arterial aging and is solidified by TGFβ1 through a cluster of mechano-
sensitive α5β1 and αvβ3 integrins.
Figure 6. Traction stress maps of isolated VSM cells. (a) Representative phase contrast and traction field images 
of young vs. old VSM cells adhered to an elastic gel coated with type I collagen (Young’s modulus of 8 kPa with 
a Poisson’s ratio of 0.48). The white lines show the cell boundary, colors show the magnitude of the tractions in 
Pascal (Pa) indexed to the color bar at the right, and arrows show the direction and relative magnitude of the 
tractions. Scale bar is 50 μm. As described45,48, for each individual adherent cell, we computed (b) projected 
area; (c) root mean square (RMS) traction; (d) maximum cumulative force; (e) total strain energy; (f) prestress; 
and, (g) net contractile moments. Data are presented as Mean ± SE (n = 8–10 individual cells per group).
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Conclusion
With each beat of the heart, and each thrust of the stroke volume, an elastic response of the central arteries fash-
ions, in turn, cardiovascular health and long-lived human physiology. With aging, however, there is a general 
breakdown of vascular distensibility/elasticity which is marked by inflammation, fibrosis and stiffening in the 
arterial wall. Using an experimental model of arterial aging, here we identified age-associated stiffening of the 
VSM. This phenotypic expression of increased cytoskeletal stiffness in old VSM cells was maintained in culture 
and persistent across a wide range of matrix rigidity. Using siRNA-mediated knockdown of TGFβ1, and pharma-
cological inhibition of TGFβ1 receptor signal transduction, we further demonstrated that this long-range mate-
rial stiffness of the actin cytoskeletal network is positively associated with TGFβ1 expression and activation and, 
on multiple time and length scales, reinforced through a cluster of mechanosensitive integrin receptors α5β1 and 
αvβ3. Taken together, these studies serve as a proof-of-concept that the broad-based inhibition of TGFβ1 expres-
sion, or activation, targeted at the structural cell-types of VSM may be a useful therapeutic approach to mitigate 
the pathologic progression of central arterial wall stiffening associated with aging.
Materials and Methods
Material and reagents. Human recombinant TGFβ1 was purchased from R&D systems (Catalog # 
204B), and TGFβ1 type I receptor inhibitors, A-83-01 and GW788388, were purchased from Sigma-Aldrich 
(Catalog # SML0788 and Catalog # SML0116). All primary antibodies and HRP-conjugated goat anti-rabbit IgG 
used in this study were obtained from Cell Signaling Technology and used as directed by the manufacturer’s 
recommendations.
Animals. Male Fisher 344 crossbred Brown Norway rats (F344XBN; 8-month-old and 30-month-old) were 
obtained from the National Institute on Aging Contract Colonies (Harlan Sprague Dawley, Inc., Indianapolis, IN). 
The animal protocol used was approved by the Institutional Animal Care and Use Committee of the Gerontology 
Research Center and complied with the guide for the care and use of laboratory animals (NIH publication No. 
3040-2, revised 1999).
VSM cell isolation and culture. Vascular smooth muscle (VSM) cells were enzymatically isolated and 
cultured as previously described46,47. Briefly, F344XBN rat thoracic aortas were rinsed in Hanks balanced salt 
solution (HBSS) containing 50 μg/mL penicillin, 50 μg/mL streptomycin and 0.25 μg/mL amphotericin B (Gibco). 
After digestion for 30 min with 2 mg/mL collagenase I solution (Worthington Biomedical, Freehold, New Jersey) 
at 37 °C, the adventitia and intima layers were removed, and the vessel media was further digested with 2 mg/mL 
collagenase II/0.5 mg/mL elastase (Sigma) for 1 h at 37 °C. The isolated cells were washed and plated in complete 
medium. In all cases, >95% of cells stained positive for α-smooth muscle actin (α-SMA) and smooth muscle 
myosin heavy chains (SM1 and SM2) (Suppl. Fig. 1b,c). Cells were maintained with VSMC medium including: 
DMEM (Gibco), 10% FBS (Sigma), 1% NEAA and 1% penicillin/streptomycin (Gibco). For all studies, we used 
early passage cells (passages 1–3).
Live cell micromechanical methods. Using spontaneous and forced motions of ferrimagnetic microbeads 
(~4.5 μm in diameter) functionalized to the living CSK, we detected the remodeling dynamics and the mate-
rial properties of individual primary VSM cells isolated from the thoracic aorta of adult (8 months) vs. aged 
(30 months) F334XBN rats. These methods, Spontaneous Nanoscale Tracer Motions (SNTM) and Magnetic 
Twisting Cytometry (MTC) are described in detail elsewhere26,29,31,32,34. For these studies, VSM cells were plated 
on collagen-coated plastic tissue culture 96-wells (30,000 cells/well), or, plated on collagen-coated gel blocks of 
varying rigidity (~1 to 20 kPa; 150,000 cells/block). Unless otherwise noted, prior to cell micromechanical meas-
urements, cells were incubated for 24 h with medium containing 1% FBS: all measurements were made in 1% FBS 
containing medium.
First, using SNTM, we visualized spontaneous nanoscale displacements of an individual functionalized bead 
(~50–100 beads per field-of-view) and recorded its positions at frequency of 12 frames/s for tmax ~300 s via a 
CCD camera (Orca II-ER, Hamamatsu, Japan) attached to an inverted optical microscope (Leica Microsystems, 
Bannockburn, IL). The trajectories of bead motions in two dimensions were then characterized by computing the 
mean square displacement of all beads as function of time [MSD(t)] (nm2), as previously described29. Herein, we 
analyzed MSD data for times greater than 10 s and up to 300 s. For individual cell-wells and experimental condi-
tions, diffusion coefficient D* and the exponent α of the bead motion were also estimated from a least-square fit 
of a power-law to the ensemble average of MSD data versus time.
We then applied forced motions of the same functionalized beads using MTC26,34 and measured stiffness (elas-
tic) and frictional (loss) moduli of adherent VSM cells. In brief, the ferrimagnetic beads bound to the underlying 
CSK were magnetized horizontally with a brief 1,000-Gauss pulse and twisted in a vertically aligned homogene-
ous magnetic field (20 Gauss) that was varying sinusoidally in time. This sinusoidal twisting magnetic field caused 
both a rotation and a pivoting displacement of the bead: as the bead moves, the cell develops internal stresses 
which in turn resist bead motions34. Lateral bead displacements in response to the resulting oscillatory torque 
were detected with an accuracy of 5 nm using an intensity-weighted center-of-mass algorithm34. We defined the 
ratio of specific applied torque to lateral bead displacements as the complex elastic modulus of the cell, 
⁎ = ′ + ″g f g f ig f( ) ( ) ( ), where g’ is the storage modulus (cell stiffness), g” is the loss modulus (cell friction), and 
i2 = −134. Cell stiffness and friction are expressed in units of Pascal per nm (Pa/nm).
Fourier Transform Traction Microscope (FTTM). A detailed description of this technique is provided 
by Butler and colleagues45,48 and in our previous study26. In brief, cells were plated sparsely on elastic gel blocks 
(~1,500 cells per gel block) coated with collagen type I, and allowed to adhere and stabilize for 24 h. For each 
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adherent cell, images of fluorescent microbeads (0.2 μm in diameter, Molecular Probes, Eugene, OR) embedded 
near the gel apical surface was taken at different times; the fluorescent image of the same region of the gel after 
cell detachment with trypsin was used as the reference (traction-free) image. The displacement field between a 
pair of images was then obtained by identifying the coordinates of the peak of the cross-correlation function45,48. 
From the displacement field and known elastic properties of the gel, the traction field was computed using both 
constrained and unconstrained Fourier transform traction cytometry45,48. For these studies, we tuned the elastic 
gels in a physiological range of arterial wall stiffness (i.e. Young’s moduli of 8 kPa to 20 kPa with Poisson’s ratio 
of 0.48).
Tension Gauge Tether (TGT) synthesis. Tension gauge tether (TGT) was fabricated as described44. 
Cyclic peptide RGDfK (cRGDfK, PCI-3696-PI, Peptides International, Inc) was conjugated to the 3′ end of an 
18-nucleotide single stranded DNA (ssDNA; 5-/5Cy3/GGC CCG CAG CGA CCA CCC/3ThioMC3-D/3) using a 
hetero-bifunctional cross-linker (Sulfo-SMCC, Thermo Fisher Scientific Inc.). The Sulfo-SMCC has a maleimide 
group reacting with a thiol group on the thiol modified ssDNA, as well as a NHS ester group reacting with an 
amine group on cRGDfK. These functional groups result in the cRGDfK conjugated ssDNA. Next, a comple-
mentary ssDNA (5-GGG TGG TCG CTG CGG GCC-3) with biotin at different locations determining different 
tension tolerances (Ttol, 23 pN and 54 pN) was annealed to the cRGDfK conjugated ssDNA (as depicted in the 
Suppl. Fig. 9).
Cell adhesion on TGT surfaces. To determine molecular tension exerted on a single integrin-ligand 
bond during VSM cell adhesion, TGT surfaces were prepared following a protocol used in our previous works44. 
1 µM TGTs with different tension tolerances (23 and 54 pN) were immobilized on a PEGylated glass slide via 
a neutravidin-biotin interaction. Since the PEGylated glass surface is a non-fouling surface, cell adhesion was 
allowed only at the TGT coated region. VSM cells were collected from a culture dish and re-dispersed in a 
serum-free DMEM medium. The cells were loaded onto the TGT surfaces at the density of 3.75 × 104 cells/ml. 
After 30 min or 2 h incubation at 37 °C, the cells were fixed using a 4% para-formaldehyde solution. DIC images of 
the fixed cells and fluorescence images of the TGT rupture patterns were taken by an epi-fluorescence microscope 
(Nikon Ti-E, Nikon Inc.). Projected area and the number of adherent cells on each TGT surface were analyzed 
using ImageJ.
Immunostaining of integrin α5β1 and αvβ3 expressed on VSM cells. Expression levels of α5β1 
and αvβ3 integrins on VSM cells were characterized by immunostaining. In brief, the cells were fixed with a 4% 
para-formaldehyde solution for 10 min and washed with a PBS solution three times. The cells were permeabilized 
by a 0.5% Triton-X solution, and incubated with either anti-integrin α5β1 antibody (MAB1969, Millipore, USA) 
or anti-integrin αvβ3 antibody (sc-7312 AF488, Santa Cruz Biotechnology, USA). FITC-conjugated secondary 
antibody (Goat anti-mouse antibody-FITC, F-2761, Thermo Fisher Scientific, Inc.) was then added for the flu-
orescence imaging. The fluorescence intensity of α5β1 or αvβ3 integrin in an individual cell was measured by 
ImageJ, and the relative intensity was plotted using the Origin software (OriginLab Coporation).
Immunostaining of focal adhesion and actin cytoskeleton. Similar to the integrin staining described 
above, vinculin was stained by sequential addition of primary and secondary antibodies using a commercial 
focal adhesion staining kit (FAK100, Millipore). Simultaneously, actin filaments were stained by TRITC-labeled 
Phalloidin, and the nucleus was stained by DAPI. Focal adhesion, actin, and DAPI in the fixed VSM cells adhered 
to the TGT surfaces were visualized by an epi-fluorescence microscope (Nikon Ti-E, Nikon Inc.).
Enzyme-linked immunosorbent assay for TGFβ1. Enzyme-linked immunosorbent assay kit for 
detection of TGFβ1 was obtained from R&D Systems and experiments followed the manufacturer’s suggested 
guidelines and as described previously49. In brief, young and old VSM cells were cultured in 25-cm2 flask and sub-
sequently serum deprived for 12 h. Serum free supernatants from 24-h cultures were collected, and total protein 
content was determined. Cell culture supernatants were aliquoted and treated or left untreated with 1 N HCl for 
10 min to activate latent TGFβ1 to the immunoreactive form. Standard curve was generated using serial dilutions 
of human recombinant TGFβ1. Data are expressed as a pg of active TGFβ1 per mg of total protein in cell culture 
supernatants.
Western Blotting. The western blot was performed using an ECL kit (Thermo Scientific) based on the manu-
facturer’s recommendations. In brief, samples were boiled in 1 × SDS loading buffer, separated by SDS-PAGE gels, 
and transferred onto a nitrocellulose membrane, which was blocked with 5% non-fat dry milk or bovine serum 
albumin (BSA) followed by incubation with primary antibodies at 4 °C overnight. For these studies, we used rab-
bit anti-phospo-smad2 antibody (1:500), rabbit anti-smad2 antibody (1:1,000), rabbit anti-phospho-smad3 anti-
body (1:500), rabbit anti-smad3 antibody (1:1,000). HRP-conjugated goat anti-rabbit IgG was used as secondary 
antibody (1:10,000); and, signals were detected using Pierce ECL Western Blotting Substrate (Thermo Scientific). 
GAPDH (rabbit anti-GAPDH antibody, 1:4000) was used as a loading control.
Data analysis. All quantitative data were derived from multiple independent experiments, and statistical 
differences were determined by Student’s t test (comparison of two sample means) or ANOVA (comparison of 
more than two sample means). In order to satisfy the distributional assumptions associated Student’s t test and 
ANOVA, cell stiffness data were first converted to log scale prior to analyses. For normally distributed data, the 
comparisons were performed with Student’s t test and one-way ANOVA, followed by Bonferroni post hoc testing. 
The 2-sided P-values less than 0.05 were considered significant.
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